Evidence map›Paper›PMID 41795724›Full record

ArticleAngiogenesis2026

Progressive endothelial coverage enhances hemocompatibility and prevents calcification in bioprosthetic valve tissue.

Bastien Poitier, Ulysse Richez, Joseph Roux-de-Bezieux, Peter Ivak, Jeanne Rancic, Hugo Charrier, Christian Latremouille, Christophe Peronino, Jean Christian Roussel, Elisa Rossi and 9 more

Abstract read
In one paragraph

Article in Angiogenesis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Bastien PoitierINSERM PARCC Georges Pompidou European Hospital, Université Paris Cité, 56 Rue Leblanc, 75015, Paris, France.
Ulysse RichezINSERM PARCC Georges Pompidou European Hospital, Université Paris Cité, 56 Rue Leblanc, 75015, Paris, France.
Joseph Roux-de-BezieuxINSERM PARCC Georges Pompidou European Hospital, Université Paris Cité, 56 Rue Leblanc, 75015, Paris, France.
Peter IvakDepartment of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Jeanne RancicINSERM PARCC Georges Pompidou European Hospital, Université Paris Cité, 56 Rue Leblanc, 75015, Paris, France.
Hugo CharrierCarmat SA, Vélizy-Villacoublay, France.
Christian LatremouilleCarmat SA, Vélizy-Villacoublay, France.
Christophe PeroninoINSERM PARCC Georges Pompidou European Hospital, Université Paris Cité, 56 Rue Leblanc, 75015, Paris, France.
Jean Christian RousselThoracic and Cardiovascular Surgery Department, Thorax Institute, University Hospital of Nantes, Nantes, France.
Elisa RossiINSERM, Optimisation Thérapeutique en Neuropharmacologie OTEN U1144, Université Paris-Cité, 75006, Paris, France.
Salma El-BattiINSERM PARCC Georges Pompidou European Hospital, Université Paris Cité, 56 Rue Leblanc, 75015, Paris, France.
Michel KindoCardiovascular Surgery Department, University Hospital of Strasbourg, Strasbourg, France.
Bruno SaubameaPlateforme d'Imagerie Cellulaire et Moléculaire (PICMO), US25 INSERM, UAR3612 CNRS, Faculté de Pharmacie de Paris, Université Paris Cité, Paris, France.
Yuri PyaNational Research Cardiac Surgery Center, Astana, Kazakhstan.
Corinne LesaffreINSERM PARCC Georges Pompidou European Hospital, Université Paris Cité, 56 Rue Leblanc, 75015, Paris, France.
Antoine CapelCarmat SA, Vélizy-Villacoublay, France.
Paul AchouhCardiovascular Surgery Department, AP-HP, Georges Pompidou European Hospital, 75015, Paris, France.
Ivan NetukaDepartment of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
David M SmadjaINSERM PARCC Georges Pompidou European Hospital, Université Paris Cité, 56 Rue Leblanc, 75015, Paris, France. david.smadja@aphp.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExploring the hemocompatibility of bioprosthetic heart valves (BHVs) has been challenging due to the scarcity of non-degenerated material.

objectivesThis study has two complementary objectives (1) To characterize the extent and temporal kinetics of endothelial coverage of BHVs implanted in humans; (2) To investigate, in a rat model, the impact of pericardial endothelialization on tissue calcification.

methodsWe employed histology and electron microscopy to assess cellular organization in non-degenerated BHVs and conducted hemodynamic simulations to evaluate shear stress fields in the ejection valves area. Furthermore, we investigated the impact of pericardium endothelial coverage on calcification using endothelial colony-forming cells (ECFCs) cultured on bovine pericardium discs implanted in athymic nude rats for 18 days. Calcium content was quantified through acetylene flame atomic absorption spectrophotometry.

resultsWe observed inflammatory cell infiltration within all explanted BHVs, as well as fibrin deposit on top of the leaflets. Endothelial coverage emerged in long-term implants (> 180 days) but remained incomplete in aortic valves, which could be linked to high shear stress levels in aortic position confirmed in hemodynamic simulations. Besides, the rat experiments revealed that the discs covered with fibrin + ECFCs were significantly less calcified than those covered with fibrin alone (respectively, median = 0.9 µg Ca/mg tissue; IQR: 0.7–1.1 vs median = 18.3 µg Ca/mg tissue; IQR: 9–34.9; p = 0.0003), and less extensively colonized by neutrophils.

conclusionsHuman explanted BHVs showed intact leaflets with a fibrin layer and organized endothelial coverage, without detectable calcification over the short observation period. In rats, endothelialization was associated with significantly reduced pericardial calcification, suggesting a potential protective effect. However, the limited follow-up in humans precludes conclusions on a causal role of endothelial coverage in hemocompatibility or protection against calcification.

Indexed as

BioprosthesisCalcinosisEndothelial CellsHeart Valve ProsthesisAnimalsCattleHumansPericardiumRatsRats, NudeBiomaterialsBioprosthetic heart valveBioprosthetic total artificial heartBovine pericardiumCalcificationEndothelial cellsHemocompatibility

Identifiers

PMID41795724
PMCPMC12968097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.